Transport
Billings Clinic
Billings Clinic was paid $3.32M by Medicaid between Jan 2018 and Dec 2024, across 497 billing codes. Its largest line is 99283, emergency room visit (moderate) — 14% of everything it billed.
33Billing provider infoBILLINGS CLINIC
BILLINGS, MT 59101
BILLINGS, MT 59101
33aNPI1265478291assigned 06/20/2006
33bProvider typeAir Ambulance
28Total paid$3.32M
24GClaims1,986,563
24DCodes billed497
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 302,727 | $558K | |
| 2019 | 294,963 | $552K | |
| 2020 | 274,800 | $424K | |
| 2021 | 298,577 | $423K | |
| 2022 | 292,323 | $430K | |
| 2023 | 302,871 | $471K | |
| 2024incomplete | 220,302 | $459K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 45,233 | 38,976 | $454K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 36,799 | 31,912 | $403K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 9.8% | 35,305 | 30,758 | $326K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6.9% | 12,153 | 11,225 | $228K |
| 70450 | Computed tomography, head or brain; without contrast material | 5.0% | 12,314 | 10,851 | $167K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 3.2% | 196 | 192 | $105K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 2.9% | 3,183 | 2,834 | $95K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.4% | 9,505 | 8,665 | $79K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 2.2% | 1,698 | 1,617 | $73K |
| 80306 | 2.1% | 13,613 | 11,766 | $68K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 1.9% | 2,051 | 1,848 | $64K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1.5% | 5,258 | 4,724 | $51K |
485 more codes
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.4% | 30,712 | $48K |
| 80053 | Comprehensive metabolic panel | 1.4% | 124,452 | $45K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1.4% | 214 | $45K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.1% | 3,443 | $37K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 10,281 | $28K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,588 | $28K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 1,058 | $28K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 22,259 | $26K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 3,662 | $26K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 24,900 | $25K |
| 70486 | <1% | 2,052 | $24K | |
| 71250 | <1% | 1,598 | $24K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 23,907 | $23K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 314 | $23K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 82,946 | $23K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 2,330 | $22K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,516 | $22K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 584 | $22K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 16,356 | $21K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 3,941 | $21K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 12,135 | $19K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 5,040 | $18K |
| 99218 | <1% | 71 | $17K | |
| 72141 | <1% | 1,609 | $16K | |
| 85027 | <1% | 54,344 | $16K | |
| 71045 | Radiologic examination, chest; single view | <1% | 9,053 | $15K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 6,810 | $15K |
| G0378 | Hospital observation service, per hour | <1% | 16,406 | $14K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 7,123 | $14K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 628 | $11K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,046 | $11K |
| 12001 | <1% | 852 | $10K | |
| 70496 | <1% | 1,032 | $10K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,352 | $9K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 26,666 | $9K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 19,339 | $9K |
| 81001 | <1% | 36,423 | $9K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 5,592 | $9K |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 6,916 | $9K |
| 70498 | <1% | 1,171 | $9K | |
| 87492 | <1% | 25,661 | $9K | |
| 73610 | <1% | 2,471 | $8K | |
| 87592 | <1% | 25,500 | $8K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,324 | $8K |
| 81025 | <1% | 14,592 | $8K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 30,136 | $8K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 14,957 | $7K |
| 73110 | <1% | 1,392 | $7K | |
| H0035 | Mental health partial hospitalization, treatment, less than 24 hours | <1% | 15,666 | $7K |
| 73221 | <1% | 512 | $7K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 21,845 | $6K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 52,354 | $6K |
| 83690 | <1% | 15,729 | $6K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,597 | $6K |
| 70491 | <1% | 416 | $6K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 58,779 | $6K |
| 73130 | <1% | 2,178 | $6K | |
| 73630 | <1% | 2,593 | $6K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 15,916 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 20,712 | $6K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 2,049 | $6K |
| 96376 | <1% | 7,069 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 26,120 | $5K |
| 72156 | <1% | 76 | $5K | |
| 69210 | <1% | 66 | $5K | |
| 88342 | <1% | 2,144 | $5K | |
| J2704 | Injection, propofol, 10 mg | <1% | 17,598 | $5K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 18,980 | $5K |
| 12002 | <1% | 606 | $5K | |
| 87040 | <1% | 7,261 | $5K | |
| 72146 | <1% | 125 | $5K | |
| 12011 | <1% | 277 | $5K | |
| 84703 | <1% | 5,768 | $4K | |
| 93976 | <1% | 708 | $4K | |
| 82805 | <1% | 1,296 | $4K | |
| 59025 | Fetal non-stress test | <1% | 2,281 | $4K |
| 73562 | <1% | 1,652 | $4K | |
| 87081 | <1% | 8,004 | $4K | |
| 93308 | <1% | 353 | $4K | |
| 88304 | <1% | 2,419 | $4K | |
| 83605 | <1% | 5,988 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 15,399 | $4K |
| 73030 | <1% | 2,095 | $4K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 627 | $4K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 10,282 | $4K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 14,075 | $4K |
| 84484 | <1% | 15,372 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 2,010 | $3K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,756 | $3K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 502 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,029 | $3K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 820 | $3K |
| 83735 | <1% | 11,376 | $3K | |
| 73090 | <1% | 251 | $3K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 78,066 | $2K |
| 87070 | <1% | 10,033 | $2K | |
| 88300 | <1% | 690 | $2K | |
| 86140 | <1% | 12,400 | $2K | |
| 73080 | <1% | 364 | $2K | |
| 86850 | <1% | 4,351 | $2K | |
| 87077 | <1% | 12,131 | $2K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 2,383 | $2K |
| 82962 | <1% | 15,972 | $2K | |
| 88312 | <1% | 189 | $2K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 636 | $2K |
| 80143 | <1% | 520 | $2K | |
| 73564 | <1% | 1,019 | $2K | |
| 88313 | <1% | 295 | $2K | |
| 76775 | <1% | 444 | $2K | |
| 72158 | <1% | 62 | $2K | |
| 85379 | <1% | 2,908 | $2K | |
| 84702 | <1% | 5,685 | $2K | |
| 83970 | <1% | 2,763 | $2K | |
| 80061 | Lipid panel | <1% | 32,567 | $2K |
| 85007 | <1% | 5,413 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,623 | $2K |
| 76857 | <1% | 600 | $2K | |
| 76604 | <1% | 122 | $2K | |
| 87420 | <1% | 428 | $2K | |
| 99234 | <1% | 2,642 | $2K | |
| 87186 | <1% | 9,838 | $2K | |
| 86901 | <1% | 4,856 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 4,086 | $1K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 10,463 | $1K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 8,956 | $1K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 6,844 | $1K |
| 82077 | <1% | 2,059 | $1K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 4,581 | $1K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 441 | $1K |
| 83880 | <1% | 3,472 | $1K | |
| 77002 | <1% | 191 | $1K | |
| 73590 | <1% | 350 | $1K | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 1,809 | $1K |
| 87486 | <1% | 604 | $1K | |
| 87581 | <1% | 604 | $1K | |
| 87205 | <1% | 4,727 | $1K | |
| 76000 | <1% | 325 | $1K | |
| 99152 | <1% | 1,419 | $1K | |
| 82550 | <1% | 2,142 | $1K | |
| 90686 | <1% | 3,703 | $1K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 2,366 | $1K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 6,642 | $1K |
| 84439 | <1% | 10,957 | $1K | |
| 82607 | <1% | 7,563 | $1K | |
| 82728 | <1% | 8,949 | $924.68 | |
| 85610 | <1% | 13,360 | $908.10 | |
| 94760 | <1% | 1,555 | $896.62 | |
| 82746 | <1% | 4,442 | $887.38 | |
| 82784 | <1% | 2,677 | $882.46 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 1,808 | $860.08 |
| 90715 | <1% | 1,815 | $853.09 | |
| 84100 | <1% | 5,817 | $801.77 | |
| 72100 | <1% | 892 | $777.75 | |
| 86900 | <1% | 4,796 | $731.49 | |
| 87046 | <1% | 877 | $705.50 | |
| 82330 | <1% | 468 | $666.15 | |
| 76830 | Ultrasound, transvaginal | <1% | 922 | $659.60 |
| 93970 | <1% | 148 | $659.02 | |
| 73140 | <1% | 107 | $654.50 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 17,900 | $610.61 |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,607 | $601.80 |
| 80179 | <1% | 301 | $600.91 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 4,873 | $594.19 |
| 73502 | <1% | 937 | $584.80 | |
| 83540 | <1% | 9,155 | $575.93 | |
| 74018 | <1% | 114 | $571.20 | |
| 81002 | <1% | 1,919 | $542.30 | |
| 87529 | <1% | 1,221 | $509.98 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 597 | $504.45 |
| 74230 | <1% | 28 | $494.70 | |
| 90670 | <1% | 718 | $486.55 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 5,240 | $485.87 |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 2,317 | $471.21 |
| 88307 | <1% | 1,695 | $464.95 | |
| 82009 | <1% | 473 | $451.58 | |
| 85730 | <1% | 2,340 | $447.05 | |
| 20610 | <1% | 1,849 | $446.76 | |
| 10060 | <1% | 255 | $423.09 | |
| 87449 | <1% | 444 | $402.90 | |
| 76377 | <1% | 29 | $393.55 | |
| 82803 | <1% | 562 | $392.70 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,545 | $353.60 |
| 87045 | <1% | 769 | $352.75 | |
| 76942 | <1% | 709 | $351.88 | |
| 76870 | <1% | 26 | $344.25 | |
| 85652 | <1% | 7,212 | $340.36 | |
| 82565 | <1% | 4,396 | $334.69 | |
| J1815 | Injection, insulin, per 5 units | <1% | 3,164 | $326.62 |
| 80076 | <1% | 2,550 | $305.15 | |
| 97162 | <1% | 980 | $304.92 | |
| 80164 | <1% | 1,375 | $303.45 | |
| 74019 | <1% | 37 | $299.20 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 2,034 | $298.06 |
| C1769 | Guide wire | <1% | 1,372 | $293.65 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 983 | $284.53 |
| 83550 | <1% | 7,141 | $277.72 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 2,976 | $277.10 |
| 29125 | <1% | 27 | $260.10 | |
| 97161 | <1% | 1,008 | $255.00 | |
| 97165 | <1% | 182 | $252.70 | |
| 80178 | <1% | 1,987 | $250.75 | |
| 82533 | <1% | 970 | $243.10 | |
| 82247 | <1% | 681 | $224.40 | |
| 86308 | <1% | 473 | $220.15 | |
| 87210 | <1% | 860 | $211.72 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 428 | $211.69 |
| 82670 | <1% | 1,747 | $208.25 | |
| 86780 | <1% | 8,279 | $206.09 | |
| 85651 | <1% | 3,229 | $196.35 | |
| 85014 | <1% | 1,760 | $185.69 | |
| 86703 | <1% | 15,992 | $184.80 | |
| 81003 | <1% | 2,073 | $175.45 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 703 | $170.00 |
| 74022 | <1% | 12 | $164.05 | |
| 85046 | <1% | 1,032 | $163.20 | |
| 85018 | <1% | 1,536 | $156.39 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 723 | $154.70 |
| 82248 | <1% | 1,017 | $148.76 | |
| 72040 | <1% | 36 | $148.75 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 742 | $147.04 |
| 84550 | <1% | 4,100 | $145.57 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 2,377 | $145.35 |
| 97166 | <1% | 273 | $145.35 | |
| 89050 | <1% | 179 | $142.80 | |
| J3360 | Injection, diazepam, up to 5 mg | <1% | 288 | $140.25 |
| 83001 | <1% | 2,265 | $139.40 | |
| 83002 | <1% | 1,706 | $138.55 | |
| 83615 | <1% | 2,312 | $135.15 | |
| 84481 | <1% | 4,312 | $134.85 | |
| 96367 | <1% | 199 | $132.20 | |
| 87641 | <1% | 2,383 | $130.05 | |
| 93971 | <1% | 1,672 | $127.87 | |
| 84480 | <1% | 1,417 | $123.63 | |
| 11721 | <1% | 1,928 | $123.16 | |
| 82977 | <1% | 6,220 | $116.40 | |
| 92134 | <1% | 1,669 | $115.04 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 843 | $104.62 |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 5,030 | $99.92 |
| 82140 | <1% | 311 | $98.60 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 1,667 | $97.72 |
| 87480 | <1% | 5,037 | $97.70 | |
| 87660 | <1% | 5,040 | $97.69 | |
| 87510 | <1% | 5,036 | $97.69 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 3,757 | $92.89 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 152 | $89.47 |
| 87272 | <1% | 383 | $89.25 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | <1% | 172 | $88.47 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 432 | $81.60 |
| 82570 | <1% | 8,159 | $79.65 | |
| 97116 | <1% | 191 | $73.95 | |
| 87340 | <1% | 5,112 | $71.40 | |
| 86376 | <1% | 2,596 | $68.85 | |
| 86706 | <1% | 3,714 | $68.00 | |
| 80069 | <1% | 1,464 | $64.60 | |
| 86592 | <1% | 3,691 | $58.64 | |
| 84156 | <1% | 2,869 | $56.10 | |
| 90674 | <1% | 257 | $56.09 | |
| 87102 | <1% | 51 | $53.55 | |
| 84436 | <1% | 6,887 | $51.85 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 753 | $50.15 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 448 | $43.34 |
| 92250 | <1% | 61 | $42.13 | |
| 84460 | <1% | 770 | $39.10 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 132 | $39.10 |
| 84153 | <1% | 3,298 | $39.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 192 | $38.33 |
| 84450 | <1% | 564 | $38.25 | |
| 89055 | <1% | 15 | $33.15 | |
| 82945 | <1% | 14 | $29.75 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 644 | $28.13 |
| 84157 | <1% | 14 | $27.20 | |
| 81000 | <1% | 1,097 | $27.20 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 208 | $23.80 |
| 81015 | <1% | 50 | $22.95 | |
| 90656 | <1% | 77 | $21.25 | |
| G0432 | Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening | <1% | 1,484 | $18.41 |
| A9270 | Non-covered item or service | <1% | 7,814 | $16.41 |
| 82947 | <1% | 305 | $14.05 | |
| 84132 | <1% | 395 | $11.43 | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 348 | $11.38 |
| 82043 | <1% | 5,476 | $5.35 | |
| 86431 | <1% | 2,841 | $4.60 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 46 | $3.56 |
| G0008 | Administration of influenza virus vaccine | <1% | 4,930 | $1.90 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 107 | $0.89 |
| 74420 | <1% | 15 | $0.84 | |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | <1% | 31 | $0.16 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 3,109 | $0.08 |
| 93017 | 0% | 497 | $0.00 | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 0% | 2,021 | $0.00 |
| 86708 | 0% | 1,490 | $0.00 | |
| 86709 | 0% | 70 | $0.00 | |
| 93296 | 0% | 1,742 | $0.00 | |
| 83721 | 0% | 87 | $0.00 | |
| 80074 | 0% | 4,325 | $0.00 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 311 | $0.00 |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 0% | 693 | $0.00 |
| 67028 | Intravitreal injection of a pharmacologic agent | 0% | 391 | $0.00 |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 0% | 1,103 | $0.00 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 667 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 254 | $0.00 |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 0% | 896 | $0.00 |
| 86200 | 0% | 712 | $0.00 | |
| 90662 | 0% | 865 | $0.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 1,194 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 2,699 | $0.00 |
| 84403 | 0% | 2,640 | $0.00 | |
| 83655 | 0% | 39 | $0.00 | |
| 43235 | 0% | 281 | $0.00 | |
| 83516 | 0% | 791 | $0.00 | |
| 62323 | 0% | 1,452 | $0.00 | |
| 87400 | 0% | 786 | $0.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 56 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 1,811 | $0.00 |
| 87075 | 0% | 597 | $0.00 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 4,107 | $0.00 |
| 84146 | 0% | 2,018 | $0.00 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 0% | 485 | $0.00 |
| 84466 | 0% | 243 | $0.00 | |
| C9257 | Injection, bevacizumab, 0.25 mg | 0% | 65 | $0.00 |
| 86705 | 0% | 122 | $0.00 | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 0% | 105 | $0.00 |
| 87634 | 0% | 2,357 | $0.00 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 245 | $0.00 |
| 86038 | 0% | 1,607 | $0.00 | |
| 87324 | 0% | 241 | $0.00 | |
| 84165 | 0% | 493 | $0.00 | |
| 76642 | 0% | 59 | $0.00 | |
| 72131 | 0% | 39 | $0.00 | |
| 92557 | 0% | 121 | $0.00 | |
| 51702 | 0% | 75 | $0.00 | |
| 47562 | 0% | 39 | $0.00 | |
| 69209 | 0% | 36 | $0.00 | |
| 0002A | 0% | 136 | $0.00 | |
| 86235 | 0% | 205 | $0.00 | |
| 93325 | 0% | 46 | $0.00 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 0% | 49 | $0.00 |
| 90837 | Psychotherapy session, about an hour | 0% | 394 | $0.00 |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 68 | $0.00 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 74 | $0.00 |
| 73100 | 0% | 43 | $0.00 | |
| 92550 | 0% | 13 | $0.00 | |
| 62321 | 0% | 63 | $0.00 | |
| 77080 | 0% | 30 | $0.00 | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 0% | 199 | $0.00 |
| 87106 | 0% | 13 | $0.00 | |
| 17110 | 0% | 67 | $0.00 | |
| 86334 | 0% | 24 | $0.00 | |
| 11056 | 0% | 25 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 196 | $0.00 |
| J1453 | Injection, fosaprepitant, 1 mg | 0% | 49 | $0.00 |
| 71271 | 0% | 78 | $0.00 | |
| 92579 | 0% | 16 | $0.00 | |
| 82310 | 0% | 131 | $0.00 | |
| 72070 | 0% | 45 | $0.00 | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 0% | 50 | $0.00 |
| 74178 | 0% | 13 | $0.00 | |
| 94729 | 0% | 16 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 121 | $0.00 |
| 84295 | 0% | 31 | $0.00 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 0% | 399 | $0.00 |
| 88112 | 0% | 14 | $0.00 | |
| 96116 | 0% | 13 | $0.00 | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 0% | 90 | $0.00 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 0% | 34 | $0.00 |
| 31575 | 0% | 25 | $0.00 | |
| 11100 | 0% | 39 | $0.00 | |
| 89051 | 0% | 13 | $0.00 | |
| 94664 | 0% | 14 | $0.00 | |
| 94060 | 0% | 28 | $0.00 | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 0% | 14 | $0.00 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 96 | $0.00 |
| 91322 | 0% | 17 | $0.00 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 174 | $0.00 |
| 72110 | 0% | 14 | $0.00 | |
| 84112 | 0% | 36 | $0.00 | |
| 93350 | 0% | 17 | $0.00 | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 0% | 17 | $0.00 |
| 99382 | 0% | 12 | $0.00 | |
| 88302 | 0% | 19 | $0.00 | |
| 93298 | 0% | 13 | $0.00 | |
| 20552 | 0% | 12 | $0.00 | |
| 92083 | 0% | 13 | $0.00 | |
| 77066 | Tomosynthesis, mammo | 0% | 15 | $0.00 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 0% | 67 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 5,272 | $0.00 |
| 80055 | 0% | 2,853 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 0% | 1,372 | $0.00 |
| 86704 | 0% | 2,472 | $0.00 | |
| 86803 | 0% | 11,479 | $0.00 | |
| 87269 | 0% | 282 | $0.00 | |
| 82950 | 0% | 2,494 | $0.00 | |
| 86593 | 0% | 224 | $0.00 | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 0% | 587 | $0.00 |
| 90677 | 0% | 266 | $0.00 | |
| 72170 | 0% | 57 | $0.00 | |
| 99153 | Mod sedat endo service >5yrs | 0% | 558 | $0.00 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 6,318 | $0.00 |
| 86160 | 0% | 1,038 | $0.00 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 2,845 | $0.00 |
| 87640 | 0% | 2,381 | $0.00 | |
| 87184 | 0% | 778 | $0.00 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 422 | $0.00 |
| 90792 | Psychiatric diagnostic evaluation with medical services | 0% | 242 | $0.00 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 52 | $0.00 |
| 97535 | Self-care/home management training, each 15 minutes | 0% | 467 | $0.00 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 0% | 228 | $0.00 |
| 51798 | 0% | 80 | $0.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 6,090 | $0.00 |
| 86225 | 0% | 179 | $0.00 | |
| 88341 | 0% | 256 | $0.00 | |
| J3411 | Injection, thiamine hcl, 100 mg | 0% | 1,015 | $0.00 |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 0% | 135 | $0.00 |
| 81514 | 0% | 368 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 1,810 | $0.00 |
| 90834 | Psychotherapy session, about 45 minutes | 0% | 546 | $0.00 |
| 99406 | 0% | 161 | $0.00 | |
| 84144 | 0% | 241 | $0.00 | |
| 82378 | 0% | 453 | $0.00 | |
| 99495 | 0% | 126 | $0.00 | |
| 64493 | 0% | 14 | $0.00 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 30 | $0.00 |
| 88142 | 0% | 1,444 | $0.00 | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 0% | 206 | $0.00 |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 0% | 13 | $0.00 |
| 82150 | 0% | 347 | $0.00 | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 0% | 95 | $0.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 306 | $0.00 |
| 82105 | 0% | 279 | $0.00 | |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 121 | $0.00 |
| 97802 | 0% | 29 | $0.00 | |
| 86762 | 0% | 330 | $0.00 | |
| 86304 | 0% | 142 | $0.00 | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 0% | 144 | $0.00 |
| Q3014 | Telehealth originating site facility fee | 0% | 698 | $0.00 |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 0% | 80 | $0.00 |
| 92060 | 0% | 72 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 93 | $0.00 |
| 73700 | 0% | 29 | $0.00 | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 0% | 62 | $0.00 |
| 80047 | 0% | 220 | $0.00 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 257 | $0.00 |
| 90732 | 0% | 296 | $0.00 | |
| 94010 | 0% | 42 | $0.00 | |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 439 | $0.00 |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 0% | 12 | $0.00 |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 0% | 21 | $0.00 |
| 76801 | 0% | 222 | $0.00 | |
| 95886 | 0% | 20 | $0.00 | |
| 84479 | 0% | 91 | $0.00 | |
| 87505 | 0% | 13 | $0.00 | |
| D1206 | Topical application of fluoride varnish | 0% | 12 | $0.00 |
| 76536 | 0% | 30 | $0.00 | |
| 58300 | 0% | 15 | $0.00 | |
| J0178 | Injection, aflibercept, 1 mg | 0% | 70 | $0.00 |
| 84478 | 0% | 16 | $0.00 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 68 | $0.00 |
| 86580 | 0% | 32 | $0.00 | |
| 92587 | 0% | 56 | $0.00 | |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 65 | $0.00 |
| 87625 | 0% | 25 | $0.00 | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 0% | 77 | $0.00 |
| 74183 | 0% | 30 | $0.00 | |
| 82951 | 0% | 61 | $0.00 | |
| 76819 | Fetal biophysical profile; without non-stress testing | 0% | 34 | $0.00 |
| V2632 | Posterior chamber intraocular lens | 0% | 62 | $0.00 |
| 99384 | 0% | 12 | $0.00 | |
| 82952 | 0% | 29 | $0.00 | |
| 86255 | 0% | 14 | $0.00 | |
| 96415 | 0% | 42 | $0.00 | |
| 92567 | 0% | 122 | $0.00 | |
| 93320 | 0% | 20 | $0.00 | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 0% | 30 | $0.00 |
| 17000 | 0% | 12 | $0.00 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 0% | 57 | $0.00 |
| 0001A | 0% | 112 | $0.00 | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 0% | 41 | $0.00 |
| 90480 | 0% | 18 | $0.00 | |
| 64483 | 0% | 14 | $0.00 | |
| J2305 | Injection, nitroglycerin, 5 mg | 0% | 14 | $0.00 |
| 95117 | 0% | 118 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 27 | $0.00 |
| 90847 | Family psychotherapy with the patient present, 50 minutes | 0% | 56 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 0% | 41 | $0.00 |
| C2617 | Stent, non-coronary, temporary, without delivery system | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialQUINONES, KATHLEEN (CFO)
Parent organizationBILLINGS CLINIC
| Provider | Location | Paid |
|---|---|---|
| Billings Clinic | Billings, MT | $53.85M |
| City Hospital, INC | Martinsburg, WV | $41.06M |
| Jefferson Memorial Hospital | Ranson, WV | $21.65M |
| Billings Clinic | Billings, MT | $15.71M |
| Billings Clinic | Billings, MT | $2.99M |
| Billings Clinic | Billings, MT | $2.40M |
| Billings Clinic | Cody, WY | $110K |
| Billings Clinic | Billings, MT | $97K |
| Billings Clinic | Billings, MT | $20K |
| Billings Clinic | Livingston, MT | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.